Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001 Jul;86(1):57–65
Takahashi N, Tsukamoto H, Umeyama H, Castaman G, Rodeghiero F, Ichinose A.Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. Blood 1998 Apr 15;91(8):2830–8
Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U.ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost. 1996;22(5):415–8.
Boda Z, Pfliegler G, Muszbek L, Toth A, Adany R, Harsfalvi J, Papp Z, Tornai I, Rak K. Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report. Haemostasis. 1989;19(6):348–52.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Verlag Berlin Heidelberg
About this paper
Cite this paper
Ivaskevicius, V. et al. (2007). Establishment of an International Registry of Patients with Congenital FXIII Deficiency. In: Scharrer, I., Schramm, W. (eds) 36th Hemophilia Symposium Hamburg 2005. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-36715-4_59
Download citation
DOI: https://doi.org/10.1007/978-3-540-36715-4_59
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-36714-7
Online ISBN: 978-3-540-36715-4
eBook Packages: MedicineMedicine (R0)